LifeStance Health Group, Inc. (LFST) — Financial statements
Income statement, balance sheet, and cash flow for LifeStance Health Group, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,424↑13.9% | 1,251↑18.5% | 1,056↑22.8% | 860↑28.8% | 668 | |
| Cost of Revenue | 1,018↑20.0% | 849↑12.6% | 754↑21.1% | 623↑33.6% | 466 | |
| Gross Profit | 406↑1.0% | 402↑33.2% | 302↑27.5% | 237↑17.6% | 202 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 382↑5.3% | 363↓11.6% | 411↑8.7% | 378↓12.8% | 434 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 382↑5.3% | 363↓11.6% | 411↑8.7% | 378↓12.8% | 434 | |
| Other Expenses | 0.00↓100.0% | 71↓11.8% | 80↑16.2% | 69↑27.8% | 54 | |
| Operating Expenses | 381↓12.3% | 434↓11.6% | 491↑9.8% | 447↓8.3% | 488 | |
| Total Costs & Expenses | 1,399↑9.0% | 1,283↑3.0% | 1,245↑16.4% | 1,070↑12.1% | 954 | |
| Operating Results | ||||||
| Operating Income | 26↑181.3% | -32↑83.3% | -189↑10.0% | -210↑26.6% | -286 | |
| Depreciation & Amortization | 55↓22.8% | 71↓11.8% | 80↑16.2% | 69↑27.8% | 54 | |
| EBITDA | 79↑97.6% | 40↑138.0% | -105↑26.9% | -144↑40.2% | -240 | |
| EBIT | 24↑177.3% | -31↑83.2% | -185↑12.9% | -213↑27.7% | -294 | |
| Interest & Other Income | ||||||
| Net Interest Income | -12↑56.1% | -27↓25.0% | -21↓6.5% | -20↑48.8% | -39 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 12↓56.1% | 27↑25.0% | 21↑6.5% | 20↓48.8% | 39 | |
| Non-Operating Income | 2↑414.2% | -0.54↑85.8% | -4↓243.5% | 3↓66.5% | 8 | |
| Other Income / Expenses | -13↑48.7% | -26↓49.0% | -17↑22.6% | -23↑51.8% | -47 | |
| Income Before Tax | 12↑121.5% | -58↑72.1% | -207↑11.2% | -233↑30.1% | -333 | |
| Income Tax Expense | 3↑1688.2% | -0.17↑99.2% | -20↓18.4% | -17↑33.7% | -26 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 10↑116.8% | -57↑69.2% | -186↑13.6% | -216↑29.8% | -307 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 10↑116.8% | -57↑69.2% | -186↑13.6% | -216↑29.8% | -307 | |
| Bottom-Line Net Income | 10↑116.8% | -57↑69.2% | -186↑13.6% | -216↑37.3% | -344 | |
| EPS (Basic) | 0.03↑120.0% | -0.15↑70.6% | -0.51↑16.4% | -0.61↑41.9% | -1.05 | |
| EPS (Diluted) | 0.02↑113.3% | -0.15↑70.6% | -0.51↑16.4% | -0.61↑41.9% | -1.05 | |
| Weighted Average Shares | 386↑1.8% | 379↑3.2% | 367↑3.4% | 355↑8.5% | 328 | |
| Weighted Average Diluted Shares | 391↑3.2% | 379↑3.2% | 367↑3.4% | 355↑8.5% | 328 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.